RENAL AND HEPATIC IMPAIRMENT BROUGHT ON BY CISPLATIN WITHOUT COMPROMISING ANTICANCER EFFICACY. RJDNMD [Internet]. 2024 Mar. 1 [cited 2024 May 18];31(1):394-406. Available from: https://jrdiabet.ro/index.php/RJDNMD/article/view/307